96 31 1 Antiviral Drug Intermediate

In the global fight against viruses, the research and development of antiviral drugs has always been a top priority in the pharmaceutical industry. Among the numerous pharmaceutical intermediates, 1 3 dimethylurea (CAS No.: 96 31 1, molecular formula: C3H8N2O) stands out as a key 96 31 1 antiviral drug intermediate, playing an irreplaceable role in the synthesis of various antiviral drugs. Shijiazhuang Kunxiangda Technology Co., Ltd., established in 2011, is a professional manufacturer of pharmaceutical intermediates and a trader of dye intermediates and other chemical raw materials. Our factory is located in the Economic and Technological Development Zone of Shijiazhuang City, Hebei Province, covering a total area of about 50 acres, with over 300 employees, including 9 professional technical staffs. Relying on advanced production technology, strict quality control systems, and rich industry experience, we are committed to providing global pharmaceutical enterprises with high-quality 1 3 dimethylurea products, detailed technical data of 96 31 1 antiviral drug intermediate, and professional solutions related to C3H8N2O, becoming a trusted partner in the field of antiviral drug R&D and production.

Basic Overview of 1 3 Dimethylurea (96 31 1, C3H8N2O)

1 3 dimethylurea, identified by96 31 1 and with the molecular formula C3H8N2O, is a colorless crystalline powder with stable chemical properties, which is the fundamental reason why it can be used as a high-quality antiviral drug intermediate. Under normal temperature and pressure, it has a melting point of 101-104°C and a boiling point of 268-270°C, and is easy to sublimate at high temperatures. Its relative molecular mass is 88.11, and it has good solubility in water, ethanol, and other polar solvents, which provides great convenience for its participation in various chemical reactions in the process of antiviral drug synthesis.

From the perspective of chemical structure, C3H8N2O (1 3 dimethylurea, 96 31 1) contains two methyl groups and a urea functional group, which endows it with excellent reactivity. It can undergo acylation, alkylation, and condensation reactions, and can be used as a core linking intermediate in the synthesis of antiviral drugs to help construct the active structure of the drug. In terms of safety, 96 31 1 has low acute toxicity, but as a pharmaceutical intermediate, its purity and impurity content have strict requirements.

Application of 96 31 1 in Antiviral Drug Synthesis (1 3 Dimethylurea, C3H8N2O)

96 31 1 (1 3 dimethylurea, C3H8N2O) is widely used in the synthesis of antiviral drugs due to its unique chemical properties. It is an important intermediate in the synthesis of nucleoside antiviral drugs, which are widely used in the treatment of influenza, hepatitis, AIDS, and other viral diseases. In the synthesis process, 1 3 dimethylurea acts as a key reaction raw material, participating in the formation of the core structure of nucleoside drugs, and its quality directly affects the yield and efficacy of the final drug.

In addition to nucleoside antiviral drugs,96 31 1 also plays an important role in the synthesis of non-nucleoside antiviral drugs. For example, in the synthesis of some anti-herpes virus drugs, 1 3 dimethylurea is used as a crosslinking agent to improve the stability and bioavailability of the drug. With the continuous emergence of new viruses and the increasing demand for antiviral drugs, the application prospects of 1 3 dimethylurea (C3H8N2O) as an antiviral drug intermediate are becoming broader and broader.

Quality Control of 1 3 Dimethylurea (96 31 1, C3H8N2O) as Antiviral Intermediate

As a 96 31 1 antiviral drug intermediate, the quality of 1 3 dimethylurea (C3H8N2O) is crucial to the safety and efficacy of antiviral drugs. Shijiazhuang Kunxiangda Technology Co., Ltd. has established a complete and strict quality control system covering the entire process from raw material selection to finished product delivery. In terms of raw material procurement, we have established long-term cooperative relationships with high-quality raw material suppliers, and each batch of raw materials must undergo strict testing to ensure that they meet the production requirements of 1 3 dimethylurea.

In the production process, we adopt advanced automated production equipment and precision detection instruments to monitor key parameters such as reaction temperature, pressure, and time in real time. Our 9 professional technical staffs have rich experience in the field of pharmaceutical intermediate synthesis and can promptly adjust the production process according to the detection results to ensure the stability of product quality.

FAQs: 1 3 dimethylurea, 96 31 1 & C3H8N2O antiviral intermediate

What purity of 96 31 1 (1 3 dimethylurea) do you provide?

We provide 1 3 dimethylurea (96 31 1, C3H8N2O) antiviral drug intermediate with a purity of morse than 99.0%, and can also provide products with a purity of 99.5% or above according to customer needs. The purity is tested by HPLC, and the test data is accurate and reliable. High purity ensures that our products do not contain harmful impurities that affect the quality of antiviral drugs, which can effectively improve the yield of drug synthesis and reduce the risk of side effects of the final drug. Each batch of products is accompanied by a detailed quality inspection report, which clearly records the purity and other key indicators for customers' reference and inspection.

Why is your 96 31 1 suitable for antiviral synthesis?

Our 96 31 1 (1 3 dimethylurea, C3H8N2O) has three core advantages suitable for antiviral drug synthesis. First, the chemical properties are stable. The product has a fixed melting point, boiling point, and solubility, which ensures the stability of the reaction process and avoids the failure of the synthesis reaction due to the fluctuation of raw material properties. Second, the reactivity is excellent. The unique functional groups in the molecular structure can accurately participate in various reactions required for antiviral drug synthesis, helping to construct the active structure of the drug. Third, the impurity content is extremely low. The content of heavy metals, free amines, and other impurities is far lower than the industry average, which can avoid the introduction of harmful substances into the drug and ensure the safety of the final drug product.

Can I get C3H8N2O (1 3 dimethylurea) samples?

Of course. We provide free sample services for C3H8N2O (1 3 dimethylurea, 96 31 1) to help customers test whether the product meets their antiviral drug synthesis needs before large-scale procurement. You only need to contact our sales team through official channels and put forward a sample application. After confirming your relevant information and demand details, we will arrange to send the sample to your designated address as soon as possible.

What is the delivery time of 1 3 dimethylurea (96 31 1)?

For 1 3 dimethylurea (96 31 1, C3H8N2O) antiviral drug intermediate, we have a stable inventory of conventional specifications (purity 99.0%), and can deliver goods within 3-5 working days after receiving your order. For large-volume orders (more than 10 tons) or customized high-purity products, the delivery time is usually 7-15 working days, which depends on the production schedule. We have established strategic cooperative relationships with well-known logistics companies, which can provide fast and safe transportation services. For overseas customers, we can also handle customs clearance and other procedures on your behalf to ensure that the goods arrive at your designated address on time. We will track the logistics information throughout the process and feed it back to you in a timely manner.

Why choose your 96 31 1 antiviral intermediate?

Choosing our96 31 1 (1 3 dimethylurea, C3H8N2O) antiviral drug intermediate means choosing high quality, high cost performance, and professional services. First, we are a direct manufacturer with no intermediate links, which can provide you with competitive prices while ensuring product quality. Second, we have a strict quality control system and advanced production equipment, and the product quality is far ahead of the industry level, fully meeting the needs of antiviral drug synthesis. Third, we have a professional team composed of sales and technical personnel who can provide you with one-stop services from product consultation, sample testing, to after-sales technical support. In addition, we can provide flexible packaging specifications according to your needs to facilitate your storage and use.

Shijiazhuang Kunxiangda Technology Co., Ltd. has always adhered to the business philosophy of "quality first, customer-oriented". We deeply understand the importance of 1 3 dimethylurea (96 31 1, C3H8N2O) as an antiviral drug intermediate to the pharmaceutical industry. We will continue to increase investment in scientific research and production, continuously improve the production technology of 1 3 dimethylurea, improve product quality, and provide customers with more cost-effective products and services. If you need to know more about 1 3 dimethylurea, 96 31 1 antiviral drug intermediate, or C3H8N2O, please feel free to contact our sales team. We look forward to establishing long-term and stable cooperative relations with you and contributing to the global fight against viruses.